Page last updated: 2024-09-03

norketamine and Kidney Diseases

norketamine has been researched along with Kidney Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Armelloni, S; Berra, S; Carraro, M; Corbelli, A; Giardino, L; Guerrot, D; Ikehata, M; Li, M; Mattinzoli, D; Messa, P; Rastaldi, MP; Tourrel, F; Zennaro, C1

Other Studies

1 other study(ies) available for norketamine and Kidney Diseases

ArticleYear
Podocyte glutamatergic signaling contributes to the function of the glomerular filtration barrier.
    Journal of the American Society of Nephrology : JASN, 2009, Volume: 20, Issue:9

    Topics: Animals; Cells, Cultured; Cytoskeleton; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Exocytosis; Female; Glomerular Filtration Rate; Glutamic Acid; Ketamine; Kidney Diseases; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Knockout; Podocytes; rab3A GTP-Binding Protein; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Signal Transduction

2009